WASHINGTON, Feb. 7, 2012 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani responded to new efforts unveiled today by the Administration to combat Alzheimer's Disease: (Logo: http://photos.prnewswire.com/prnh/20091027/PHRMALOGO) "Alzheimer's disease is one of America's top health challenges. It ravages the minds of patients, seriously impacts ... read more

America’s biopharmaceutical research companies are testing 88 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a report ... read more

PhRMA Unveils Alzheimer's Video Series, Highlights Medicines in Development WASHINGTON, Nov. 21, 2011 /PRNewswire-USNewswire/ -- In honor of Alzheimer's disease month, the Pharmaceutical Research and Manufacturers of America (PhRMA) produced a compelling video series highlighting the impact this devastating disease has on patients, caregivers and the U.S. health care system. To help ... read more

More than 400 of the record 901 biotechnology medicines in development today are being created by biopharmaceutical companies with major operations in California, a new report shows. ... read more

Nearly 250 – more than a fourth – of the record 901 cutting-edge biotechnology medicines in development today are being created by biopharmaceutical research companies with operations in ... read more

Results Shed Light on Potential Consequences of Imposing Government Price Controls on Medicare Part D WASHINGTON, Sept. 27, 2011 /PRNewswire-USNewswire/ -- Thousands of jobs in Texas supported by the biopharmaceutical research sector would be threatened if harmful policies - such as imposing new taxes in the Medicare prescription drug program ... read more

Results Shed Light on Potential Consequences of Imposing Government Price Controls on Medicare Part D WASHINGTON, Sept. 27, 2011 /PRNewswire-USNewswire/ -- Thousands of jobs in Ohio supported by the biopharmaceutical research sector would be threatened if harmful policies - such as imposing new taxes in the Medicare prescription drug program - ... read more

Results Shed Light on Potential Consequences of Imposing Government Price Controls on Medicare Part D WASHINGTON, Sept. 27, 2011 /PRNewswire-USNewswire/ -- Thousands of jobs in Michigan supported by the biopharmaceutical research sector would be threatened if harmful policies - such as imposing new taxes in the Medicare prescription drug program - ... read more